Palos Park, IL, United States of America

Michelle L Shields

This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle L Shields. Retrieved from https://idiyas.com/inventor/michelle-l-shields

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michelle L Shields: Innovator in Immunoassays

Introduction

Michelle L Shields is a prominent inventor based in Palos Park, IL (US). She has made significant contributions to the field of immunoassays, particularly in reducing cross-reactivity with hydrophobic drug analyte metabolites. Her work is crucial for improving diagnostic accuracy in medical testing.

Latest Patents

Michelle holds a patent titled "Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites." This patent provides innovative immunoassays that minimize cross-reactivity with analyte metabolites. The technology is particularly beneficial for determining the concentration of hydrophobic drugs, such as immunosuppressants like cyclosporine A, in test samples.

Career Highlights

Michelle is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on developing advanced diagnostic tools that enhance patient care. With 1 patent to her name, she has established herself as a key player in her field.

Collaborations

Michelle has collaborated with notable colleagues, including Elaine Marie Brate and David M Finley. These partnerships have contributed to the advancement of her research and the successful development of innovative immunoassay technologies.

Conclusion

Michelle L Shields is a dedicated inventor whose work in immunoassays has the potential to significantly impact the medical diagnostics field. Her innovative approaches continue to pave the way for advancements in healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…